Adam Mostafa Biography and Net Worth

Mr. Mostafa has served as X4’s Chief Financial Officer since September 2018. Prior to joining X4, Mr. Mostafa served as chief financial officer of Abpro Corporation, a biotechnology company focused on antibody therapeutics. Prior to that, Mr. Mostafa was a managing director in the healthcare investment banking group at Cantor Fitzgerald, and was a senior banker in the healthcare investment banking group at Needham & Company. Prior to that, Mr. Mostafa was a vice president in the investment banking group at CRT Capital Group, and was a portfolio management associate in the global stock selection group at AQR Capital. He began his career as an analyst in the healthcare investment banking group at Salomon Smith Barney. Mr. Mostafa earned an A.B. in Economics from Brown University.

What is Adam S. Mostafa's net worth?: The estimated net worth of Adam S. Mostafa is at least $63,918.75 as of February 12th, 2024. Mr. Mostafa owns 52,500 shares of X4 Pharmaceuticals stock worth more than $63,919 as of April 18th. This net worth evaluation does not reflect any other assets that Mr. Mostafa may own. Additionally, Mr. Mostafa receives an annual salary of $699,180.00 as CFO at X4 Pharmaceuticals. Learn More about Adam S. Mostafa's net worth.
How old is Adam S. Mostafa?: Mr. Mostafa is currently 43 years old. There are 7 older executives and no younger executives at X4 Pharmaceuticals. The oldest executive at X4 Pharmaceuticals is Dr. Robert David Arbeit, Senior Vice President of Clinical Development and Translational Research, who is 76 years old. Learn More on Adam S. Mostafa's age.
What is Adam S. Mostafa's salary?: As the CFO of X4 Pharmaceuticals, Inc., Mr. Mostafa earns $699,180.00 per year. The highest earning executive at X4 Pharmaceuticals is Dr. Paula Ragan Ph.D., CEO, President & Director, who commands a salary of $963,580.00 per year. Learn More on Adam S. Mostafa's salary.
How do I contact Adam S. Mostafa?: The corporate mailing address for Mr. Mostafa and other X4 Pharmaceuticals executives is 955 Massachusetts Avenue 4th Floor, Cambridge MA, 02139. X4 Pharmaceuticals can also be reached via phone at (857) 529-8300 and via email at [email protected]. Learn More on Adam S. Mostafa's contact information.
Has Adam S. Mostafa been buying or selling shares of X4 Pharmaceuticals?: Adam S. Mostafa has not been actively trading shares of X4 Pharmaceuticals during the past quarter. Most recently, Adam S. Mostafa sold 52,500 shares of the business's stock in a transaction on Monday, March 11th. The shares were sold at an average price of $0.88, for a transaction totalling $46,200.00. Learn More on Adam S. Mostafa's trading history.
Who are X4 Pharmaceuticals' active insiders?: X4 Pharmaceuticals' insider roster includes Derek Meisner (General Counsel), Adam Mostafa (CFO), and Paula Ragan (CEO). Learn More on X4 Pharmaceuticals' active insiders.
Are insiders buying or selling shares of X4 Pharmaceuticals?: During the last twelve months, X4 Pharmaceuticals insiders bought shares 1 times. They purchased a total of 25,000 shares worth more than $30,000.00. During the last twelve months, insiders at the sold shares 24 times. They sold a total of 901,833 shares worth more than $790,527.04. The most recent insider tranaction occured on March, 11th when insider Arthur Taveras sold 14,235 shares worth more than $12,526.80. Insiders at X4 Pharmaceuticals own 1.1% of the company. Learn More about insider trades at X4 Pharmaceuticals.
Information on this page was last updated on 3/11/2024.

Adam S. Mostafa Insider Trading History at X4 Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2024	Sell	52,500	$0.88	$46,200.00
2/12/2024	Sell	27,721	$1.01	$27,998.21	52,500
11/1/2023	Sell	230,645	$0.73	$168,370.85	80,221
6/30/2023	Sell	2,641	$1.89	$4,991.49	80,221
6/23/2023	Sell	5,417	$1.93	$10,454.81	82,862
6/15/2023	Sell	5,417	$2.22	$12,025.74	88,279
2/13/2023	Sell	27,721	$0.93	$25,780.53	146,196
8/17/2021	Sell	10,832	$5.10	$55,243.20
6/30/2021	Sell	2,641	$6.64	$17,536.24
6/24/2021	Sell	5,417	$7.01	$37,973.17	139,835
6/15/2021	Sell	5,417	$7.84	$42,469.28	129,002
9/21/2020	Sell	10,834	$7.08	$76,704.72
6/30/2020	Sell	1,725	$9.04	$15,594.00	8,839

Adam S. Mostafa Buying and Selling Activity at X4 Pharmaceuticals

X4 Pharmaceuticals Company Overview

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase II clinical trial to treat congenital, idiopathic, or cyclic neutropenia. The company is also developing X4P-003, a CXCR4 antagonist for the treatment of CXCR4 dependent disorders and primary immunodeficiencies; and X4P-002, a CXCR4 antagonist for the treatment of blood-brain barrier diseases. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company is headquartered in Boston, Massachusetts.

Today's Range

Now: $1.20

$1.18

$1.24

50 Day Range

MA: $1.11

$0.84

$1.47

2 Week Range

Now: $1.20

$0.57

$2.58

Volume

1,727,074 shs

Average Volume

2,155,183 shs

Market Capitalization

$201.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Adam Mostafa Biography and Net Worth

What is Adam S. Mostafa's net worth?

How old is Adam S. Mostafa?

What is Adam S. Mostafa's salary?

How do I contact Adam S. Mostafa?

Has Adam S. Mostafa been buying or selling shares of X4 Pharmaceuticals?

Who are X4 Pharmaceuticals' active insiders?

Are insiders buying or selling shares of X4 Pharmaceuticals?